SEARCH HEALTH CONDITIONS BY ALPHABETS
Hyperlipoproteinemia, Fredrickson Type V
Medications for Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL
Other titles: Fredrickson Type V Hyperlipoproteinemia; Hyperlipoproteinemia, Fredrickson Type V
About Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL: Hyperlipoproteinemia Type V is characterized by elevated plasma levels of chylomicrons, VLDL, pre-β-lipoproteins, and triglycerides, along with minor increase of cholesterol on a diet, with β-lipoproteins standard.
Drugs Used to Heal Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL
The following set of medications are found in the treatment of this illness, or in some way associated with.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| fenofibrate | Rx | C | N | Insert inspection | 10 | ||
Generic title: fenofibrate systemic Brand titles: TriCor, Antara, Fenoglide, Lofibra, Lipofen, Tri-glide ...reveal all Medicine category: fibric acid derivatives For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| TriCor | Rx | C | N | Insert inspection | 10 | ||
Generic title: fenofibrate systemic Medicine category: fibric acid derivatives For users: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| Niaspan | Rx/OTC | C | N | X | Insert inspection | 0.0 | |
Generic title: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic brokers For users: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| gemfibrozil | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: gemfibrozil systemic Brand title: Lopid Medicine category: fibric acid derivatives For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| niacin | Rx/OTC | C | N | X | Insert inspection | 0.0 | |
Generic title: niacin systemic Brand titles: Niaspan, Niacin SR, Nicotinex, Slo-Niacin, Niacor, B3-500-Gr, B-3-50...reveal all Medicine category: nutritional supplements, miscellaneous antihyperlipidemic brokers For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Antara | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: fenofibrate systemic Medicine category: fibric acid derivatives For users: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| Fenoglide | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: fenofibrate systemic Medicine category: fibric acid derivatives For users: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| Lofibra | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: fenofibrate systemic Medicine class: fibric acid derivatives For users: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| Niacin SR | Rx/OTC | C | N | X | Insert inspection | 0.0 | |
Generic title: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic brokers For users: dose, interactions, side effects | |||||||
| Lipofen | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: fenofibrate systemic Medicine category: fibric acid derivatives For users: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| Tri-glide | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: fenofibrate systemic Medicine category: fibric acid derivatives For users: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| Nicotinex | Rx/OTC | C | N | X | Insert inspection | 0.0 | |
Generic title: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic brokers For users: dose, interactions, side effects | |||||||
| Slo-Niacin | Rx/OTC | C | N | X | Insert inspection | 0.0 | |
Generic title: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic brokers For users: dose, interactions, side effects | |||||||
| Niacor | Rx/OTC | C | N | X | Insert inspection | 0.0 | |
Generic title: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic brokers For users: dose, interactions, side effects For professionals: Prescribing Information | |||||||
| B3-500-Gr | Rx/OTC | C | N | X | Insert inspection | 0.0 | |
Generic title: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic brokers For users: dose, interactions, side effects | |||||||
| Lopid | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: gemfibrozil systemic Medicine category: fibric acid derivatives For users: dose, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| B-3-50 | Rx/OTC | C | N | X | Insert inspection | 0.0 | |
Generic title: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic brokers For users: dose, interactions, negative effects | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Off Label | This medication might not be accepted by the FDA for treating the illness. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to present a risk to the fetus within the first trimester of pregnancy (also there isn`t any evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in elderly women. |
| C | Animal research studies have demonstrated a negative effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved in used in elderly women obviously outweigh potential benefits. |
| N | FDA has not classified the drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | isn`t subject to the Controlled Substances Act. |
| 1 | includes a higher possibility of abuse. Has no currently accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision. |
| 2 | includes a higher possibility of abuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Psychotherapy can lead to severe psychological or physical dependency. |
| 3 | includes a potential for abuse less than individuals in programs 1 and 2 two. Has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to physical dependence or high psychological dependence. |
| 4 | includes a very low potential for abuse relative to individuals in program 3. It`s a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence. |
| 5 | includes a very low potential for abuse relative to individuals in program 4. Has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence. |
| Infection | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always consult with your physician to make sure the information displayed on this page relates to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
